作者:
Bartlett,J. [1]
;
Canney,P. [2]
;
Campbell,A. [3]
;
Cameron,D. [4]
;
Donovan,J. [5]
;
Dunn,J. [6]
;
Earl,H. [7]
;
Francis,A. [8]
;
Hall,P. [9]
;
Harmer,V. [10]
;
Higgins,H. [11]
;
Hillier,L. [12]
;
Hulme,C. [13]
;
Hughes-Davies,L. [14]
;
Makris,A. [15]
;
Morgan,A. [16]
;
McCabe,C. [17]
;
Pinder,S. ;
Poole,C. ;
Rea,D. ;
Stallard,N. ;
Stein,R.
作者单位:
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
[1]
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United
[2]
Department of Clinical Oncology, Mount Vernon Hospital, Northwood, United Kingdom
[3]
School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
[4]
Department of Oncology, Addenbrookes Hospital, Cambridge, United Kingdom
[5]
Arden Cancer Centre, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
[6]
Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
[7]
Department of Oncology, UCL Hospitals, London, United Kingdom, UCLH/UCL, NIHR Biomedical Research
[8]
Department of Emergency Medicine Research, Edmonton, Canada
[9]
Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds
[10]
Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom
[11]
Department of Breast Surgical Oncology, University Hospitals Birmingham, Queen Elizabeth Hospital
[12]
Department of Medical Oncology, Edinburgh University and NHS Lothian, Edinburgh, United Kingdom
[13]
St Mary's Hospital, London, United Kingdom
[14]
Independent Cancer Patients Voice, London, United Kingdom
[15]
Warwick Medical School, University of Warwick, Coventry, United Kingdom
[16]
Ontario Institute for Cancer Research, Toronto, ON, Canada
[17]
发布时间
2013-11-20